TendoMend

Company Overview

Snapshot

Founded in February 2019 by Ehud (Udi) Almon and Ioannis Valavanis, TendoMend operated with 1–10 employees. The company raised $3 million across one funding round from NGT3. TendoMend ceased operations in July 2025.

Business overview

TendoMend is a Health Tech & Life Sciences company focused on developing a minimally invasive implant and deployment system for tendon repair. Its core product, the Dynamic Tendon Grip (DTG) device, is designed to replace traditional suturing methods by embracing the tendon externally, aiming to reduce trauma and improve recovery. The company operates within the medical devices, surgery, rehabilitation, and orthopedics sectors, targeting a global market with its B2B business model.

Company Intelligence Q&A

What is TendoMend's primary focus?

TendoMend is developing a minimally invasive implant and deployment system for the repair of tendon ruptures, aiming to replace traditional suturing approaches.

When was TendoMend founded and by whom?

TendoMend was founded in February 2019 by Ehud (Udi) Almon and Ioannis Valavanis.

What is the status of TendoMend?

TendoMend is non-active and ceased to operate in July 2025.

What is the Dynamic Tendon Grip (DTG) device?

The DTG device is a miniaturized implant and dedicated applicator developed by TendoMend. It establishes an external grip on the tendon to prevent damage and allow for a stronger, less traumatic connection, maintaining the original tendon profile.

What was TendoMend's last disclosed funding round?

TendoMend secured $3 million in a Seed funding round in March 2019 from NGT3.